325 related articles for article (PubMed ID: 32172653)
1. Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease.
Golledge J; Rowbotham S; Velu R; Quigley F; Jenkins J; Bourke M; Bourke B; Thanigaimani S; Chan DC; Watts GF
J Am Heart Assoc; 2020 Mar; 9(6):e015355. PubMed ID: 32172653
[TBL] [Abstract][Full Text] [Related]
2. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
[TBL] [Abstract][Full Text] [Related]
3. Association between stress hormones and perioperative risk in patients with critical limb ischemia undergoing revascularization.
Soga Y; Takahara M; Iida O; Kodama A; Azuma N;
J Vasc Surg; 2019 Sep; 70(3):795-805.e1. PubMed ID: 30857850
[TBL] [Abstract][Full Text] [Related]
4. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
[TBL] [Abstract][Full Text] [Related]
6. Impact of High Lipoprotein(a) Levels on Clinical Outcomes Following Peripheral Endovascular Therapy.
Tomoi Y; Takahara M; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
JACC Cardiovasc Interv; 2022 Jul; 15(14):1466-1476. PubMed ID: 35863797
[TBL] [Abstract][Full Text] [Related]
7. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis.
Forbang NI; Criqui MH; Allison MA; Ix JH; Steffen BT; Cushman M; Tsai MY
J Vasc Surg; 2016 Feb; 63(2):453-8. PubMed ID: 26518096
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease.
Singh TP; Morris DR; Smith S; Moxon JV; Golledge J
Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):220-233. PubMed ID: 28666785
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.
Gurdasani D; Sjouke B; Tsimikas S; Hovingh GK; Luben RN; Wainwright NW; Pomilla C; Wareham NJ; Khaw KT; Boekholdt SM; Sandhu MS
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3058-65. PubMed ID: 23065826
[TBL] [Abstract][Full Text] [Related]
10. Perioperative cardiovascular complications rate and activity of coagulation and fibrinolysis among patients undergoing vascular surgery for peripheral artery disease and abdominal aortic aneurysm.
Polok K; Górka J; Fronczek J; Iwaniec T; Górka K; Szczeklik W
Vascular; 2021 Feb; 29(1):134-142. PubMed ID: 32600160
[TBL] [Abstract][Full Text] [Related]
11. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events.
Thomas PE; Vedel-Krogh S; Nielsen SF; Nordestgaard BG; Kamstrup PR
J Am Coll Cardiol; 2023 Dec; 82(24):2265-2276. PubMed ID: 38057068
[TBL] [Abstract][Full Text] [Related]
13. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
14. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.
Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ
Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795
[TBL] [Abstract][Full Text] [Related]
15. Editor's Choice - Cohort Study Examining the Association Between Abdominal Aortic Size and Major Adverse Cardiovascular Events in Patients with Aortic and Peripheral Occlusive and Aneurysmal Disease.
Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
Eur J Vasc Endovasc Surg; 2021 Dec; 62(6):960-968. PubMed ID: 34740532
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
Zierfuss B; Höbaus C; Feldscher A; Hannes A; Mrak D; Koppensteiner R; Stangl H; Schernthaner GH
Atherosclerosis; 2022 Dec; 363():94-101. PubMed ID: 36280470
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
Desai U; Kharat A; Hess CN; Milentijevic D; Laliberté F; Zuckerman P; Benson J; Lefebvre P; Hiatt WR; Bonaca MP
Ann Vasc Surg; 2021 Aug; 75():217-226. PubMed ID: 33819600
[TBL] [Abstract][Full Text] [Related]
19. Association of gout with major adverse cardiovascular events and all-cause mortality in patients with peripheral artery disease.
Singh TP; Wong S; Quigley F; Jenkins J; Golledge J
Atherosclerosis; 2020 Nov; 312():23-27. PubMed ID: 32947223
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
